To Bless You

God Bless Everyone

Marc Beer: Improving the Health Industry

Marc Beer is an American businessman known for his desire to develop the health sector of the United States. He is the founder of Renovia Inc., a medical and technological firm based in Boston, Massachusetts. Marc Beer spent most of his life in the medical industry, and through the years, he was able to improve his skills managing businesses that are within the industry. The decision to enter the healthcare industry came up after he realized that a lot of people around the world does not have access to excellent healthcare. He thought that establishing a firm that would introduce new ways to treat numerous diseases would help the public.

 

One of the disorders that caught his attention is the pelvic floor disorder. He realized that millions of women around the world are having problems with their pelvic floor muscles, and one of the things that should be done to help ease their situation is to offer an alternative treatment. Based on current statistics, 250 million women have pelvic floor disorder, and they needed a quick treatment for their disorder. What his team at Renovia Inc. came up with is a digital system called the Leva. The Leva Digital System was approved by the FDA, and it went on sale last April 2018.

 

Specialists have recommended the use of Leva Digital System because of its effectiveness in treating pelvic floor disorders. Those who have used it stated that the instance of incontinence drastically fell right after they followed the exercises shown on the system. To use it effectively, the Leva Digital System should be connected to a smartphone or a tablet computer, and it would result in a series of exercises being flashed on the screen. The user can follow the exercise, and using the system for five minutes each day would result in a stronger pelvic floor muscle.

 

The Leva Digital System was widely acclaimed by those who are practicing in the medical industry. They stated that the system really helped with the treatment of those who are suffering from the disorder. The number of those affected with pelvic floor disorders has also dwindled right after the product was introduced. Marc Beer said that more products are still being tested at their headquarters, and people should look forward to these new treatment methods. People are thankful for the passion of Marc Beer to introduce new treatments for a wide array of diseases and disorders. Learn more: https://ideamensch.com/marc-beer/

 

Renovia Inc. is not the only company where Marc Beer currently works. Because of his contribution to the industry, many companies decided to hire him as a member of their board of directors. Companies welcome him to their board of directors, and they are trusting in his skills to improve the business. 

Follow Marc Beer on Facebook

Marc Beer

Marc Beer, an iconic individual in the medical industry, recently got hired by LumeNXT to become the head of the board. Marc Beer has been a part of the health care system for several years and has helped put various institutions. Marc’s accomplishments make him fit for the role at LumeNXT. Marc has brought about growth and development in multiple aspects of the pharmaceutical industry. For example, in biotechnology, the invention of new equipment and drugs for use in treating certain diseases. LumeNXT is a privately-owned institution that was established to develop surgical illumination products for use in minimally invasive surgery.

LumeNXT’s advanced technology is used to improve the outcome and the process of surgery generally. LumeNXT is premiering the use of LED illumination for minimally invasive procedures. Marc Beer will work with the LumeNXT team and will make use of the illumination devices to carefully and securely carry out the surgery. The team will consist of experts in Surgical Illumination and can make use of the LumeNXT tools. Marc is glad to be a part of LumeNXT and advancing the devices for global use. Marc is sure that when more medical institution incorporates minimally invasive procedures in their surgery routines, the LumeNXT technology will become widely used.

According to medical experts, the illumination devices have several advantages in surgery. Its benefits include positive results, safe approaches during surgeries, few complications since surgeons get a better view of organs while carrying out surgery. They also provide ease in doing operations. With the new illumination technology, LumeNXT has provided an excellent platform that improves accuracy during operations and improves the safety of patients. The co-founder of LumeNXT, Paul Rhyne, has faith in Marc abilities since he has since the work he has done with other institutions. Marc has assisted numerous firms in developing from the ground up; he has been a part of the growth journey of several institutions. Each firm he has worked with has emerged triumphant and has attained its vision.

Marc Beer is the founder of Renovia Inc; he established the firm in August of 2016. Renovia Inc primarily focused on pelvic floor disease. The disease mainly affects women, and from research, a large number of women from across the globe have the disease. Marc is also the founding chairperson of Minerva Neurosciences Inc. Minerva is a medical institution that primarily concentrates on finding suitable candidates to help in obtaining diagnostics for CNS disease. Apart from handling clinical trials, the organization also creates treatment products for other conditions.

Marc has worked with several institutions in the past. He has been part of the management team at various institutions. For instance, Marc was the CEO at ViaCell, where he led the firm to become a prominent institution. He also worked at Genzyme and Abbott Laboratories among others. Learn more: https://ideamensch.com/marc-beer/

Pharmaceutical Entrepreneur Marc Beer Announces The Results Of His Company’s Series B Funding Round

Marc Beer, the chief executive officer, chairman of the board of directors, and co-founder of Renovia Inc. was pleased to announce in August that his company had held a very successful Series B equity round. His company raised $42.3 million in total with $32.3 million raised in equity and another $10 million raised from venture debt.

He said that the money his company raised would be used to finance his pharmaceutical company’s clinical trials, develop the company’s products, add additional products to its pipeline, and support future commercial launches. The companies that took part in this equity round were OSF Ventures, Western Technology Investment, Inova Strategic Investments, Perceptive Advisors, Cormorant Asset Management, Ascension Ventures, and Longwood Fund. Learn more: https://renoviainc.com/

Marc Beer was pretty happy that the investors included a mix of old and new investors in his company. They could see the value of his company’s commercial and clinical vision which is all about supporting women who suffer from pelvic floor disorders. These types of disorders result from their organs pushing down on their vagina and results in a lack of bladder control and fecal incontinence.

The lack of bladder control due to pelvic floor disorder is pretty common across the globe Mark Beer says. His company, which is based in Boston, MA, has a product called Leva on the market that helps women with this disorder. They learn how to correctly perform pelvic floor muscle exercises. About 33 percent of women do these exercises incorrectly which can cause further problems if anything.

It’s estimated that over 60 percent of women age 60 and older have bladder control issues. However, their pelvic muscles can be strengthened just like any other muscle which reduces and even eliminates this problem. There are interconnected muscles in the pelvic area that, when strengthened, lead to much better bladder control.

Marc Beer is a member of the 1987 graduating class of Miami University. He entered the pharmaceutical industry in 1988 when he became the director of sales training and development at Abbott. Six years later he was a vice president at Biostar, Inc., and in May 2000 he first became a chief executive officer at ViaCell.

He has been the chairman of the board for three pharmaceutical firms which are Myolex, Good Start Genetics, and Minerva Technologies. He co-founded Renovia in August 2016. More recently, he co-founded another firm which is LumeNXT. This company creates surgical devices and is a leader in the non-tethered LED illumination field. Their product is the only device of its kind that is battery powered and offers safe and effective lighting to be used during surgical procedures.